# Revelation Biosciences, Inc.: Form 8-K, filed Nov 8, 2024

- Company: [Revelation Biosciences, Inc.](/companies/revb.md) (CIK 1810560)
- Form: 8-K
- Filed: 2024-11-08
- Accepted by EDGAR: Nov 8, 2024, 16:25 ET
- Period: 2024-11-08
- Accession: 0000950170-24-124141
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1810560/000095017024124141/revb-20241108.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810560/000095017024124141/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810560/000095017024124141/revb-20241108.htm

Filed Nov 8, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-124141. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.